Mass General Brigham Researchers Leverage Tumor Cells to Enhance Antitumor Immunity in Preclinical Cancer Models
In a significant breakthrough in cancer immunotherapy, researchers from Mass General Brigham have unveiled a pioneering strategy that leverages the ...
 
 
